Bioplatforms Australia invests in platform technologies to support Australian Life Science research, from academia and industry alike.
Research sectors benefiting from Bioplatforms Australia investment include
- Plant research
- Agriculture
- Food Industry
- Biomedical
- Pharmaceuticals
- Diagnostics
- Biotechnology
The Bioplatforms Australia investment is aimed at supporting infrastructure and expertise across the fields of
- Genomics – high throughput gene sequencing, transcript analysis, epigenetics and bioinformatics
- Proteomics – protein separation, mass spectrometry, monoclonal antibody development and protein chemistry
- Metabolomics – sample preparation, metabolite profiling, mass spectrometry
- Bioinformatics – experimental planning, data acquisition, data interrogation and data reporting
Integration of the platform technologies and services on offer through the Bioplatforms Australia investment is a key outcome of the investment. Researchers can access all aspects of the investment to maximize their research quality and output.
Bioplatforms Australia was established to manage an Australian Commonwealth Government investment through the National Collaborative Research Infrastructure Strategy (NCRIS) with support from State Governments, Academic and Research Institutes and commercial entities.